Viral Diseases
Viral Diseases(病毒性疾病)
Viral Diseases 相关产品(314)
- GC492941-(4-Chlorobenzhydryl)piperazineCAS: 303-26-4纯度: >98.00%
An inactive metabolite of meclizine and chlorcyclizine
- GC49357N-[(S)-(4-Nitrophenoxy)phenoxyphosphinyl]-L-alanine 2-ethylbutyl esterCAS: 1354823-36-1纯度: >98.00%
A synthetic intermediate
- GC49382L-Lysine-d3 (hydrochloride)CAS: 2330878-43-6纯度: >99.00%
An internal standard for the quantification of L-lysine
- GC49395Ribavirin-13C5CAS: 1646818-35-0纯度: >95.00%
An internal standard for the quantification of ribavirin
- GC49467β-Aescin (97-103%(T),beta≥60%(HPLC)(Lossondrying≤5%))CAS: 11072-93-8纯度: 不显示
A triterpenoid saponin with diverse biological activities
- GC49502(-)-β-SesquiphellandreneCAS: 20307-83-9纯度: >95.00%
A sesquiterpene with antiviral and anticancer activities
- GC495142′-Deoxyuridine-d2CAS: 40632-23-3纯度: >99.00%
An internal standard for the quantification of 2’-deoxyuridine
- GC49606Sertraline-d3 (hydrochloride)CAS: 1217741-83-7纯度: >99.00%
An internal standard for the quantification of sertraline
- GC49723SenTraGor™ Cell Senescence ReagentCAS: 2171036-89-6纯度: >95.00%
A cellular senescence detection reagent
- GC498232′-C-β-MethylguanosineCAS: 374750-30-8纯度: >95.00%
An active nucleoside metabolite of BMS-986094
- GC52224(±)-MMT5-14CAS: 2719679-31-7纯度: >98.00%
A derivative of remdesivir with antiviral activity
- GC52261Entecavir-d2CAS: 142217-69-4纯度: >99.00%
An internal standard for the quantification of entecavir
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC49228 | Ganoderol B | 104700-96-1 | >95.00% | |
A triterpenoid with diverse biological activities | ||||
| GC49265 | PKI (14-22) amide (myristoylated) (trifluoroacetate salt) | - | >98.00% | |
A PKA inhibitor | ||||
| GC49284 | GSK-A1 | 1416334-69-4 | >98.00% | |
A PI4KIIIα inhibitor | ||||
| GC49294 | 1-(4-Chlorobenzhydryl)piperazine | 303-26-4 | >98.00% | |
An inactive metabolite of meclizine and chlorcyclizine | ||||
| GC49357 | N-[(S)-(4-Nitrophenoxy)phenoxyphosphinyl]-L-alanine 2-ethylbutyl ester | 1354823-36-1 | >98.00% | |
A synthetic intermediate | ||||
| GC49382 | L-Lysine-d3 (hydrochloride) | 2330878-43-6 | >99.00% | |
An internal standard for the quantification of L-lysine | ||||
| GC49395 | Ribavirin-13C5 | 1646818-35-0 | >95.00% | |
An internal standard for the quantification of ribavirin | ||||
| GC49400 | SN-011 | 2249435-90-1 | >98.00% | |
A STING antagonist | ||||
| GC49437 | Gliotoxin-13C13 | - | >95.00% | |
An internal standard for the quantification of gliotoxin | ||||
| GC49467 | β-Aescin (97-103%(T),beta≥60%(HPLC)(Lossondrying≤5%)) | 11072-93-8 | 不显示 | |
A triterpenoid saponin with diverse biological activities | ||||
| GC49502 | (-)-β-Sesquiphellandrene | 20307-83-9 | >95.00% | |
A sesquiterpene with antiviral and anticancer activities | ||||
| GC49514 | 2′-Deoxyuridine-d2 | 40632-23-3 | >99.00% | |
An internal standard for the quantification of 2’-deoxyuridine | ||||
| GC49583 | N-desmethyl Sertraline (hydrochloride) | 675126-09-7 | >95.00% | |
A metabolite of sertraline | ||||
| GC49606 | Sertraline-d3 (hydrochloride) | 1217741-83-7 | >99.00% | |
An internal standard for the quantification of sertraline | ||||
| GC49723 | SenTraGor™ Cell Senescence Reagent | 2171036-89-6 | >95.00% | |
A cellular senescence detection reagent | ||||
| GC49749 | 6-Deoxypenciclovir | 104227-86-3 | >95.00% | |
An inactive metabolite of famciclovir | ||||
| GC49823 | 2′-C-β-Methylguanosine | 374750-30-8 | >95.00% | |
An active nucleoside metabolite of BMS-986094 | ||||
| GC49863 | Cytarabine 5′-monophosphate | 7075-11-8 | >95.00% | |
An active metabolite of cytarabine | ||||
| GC49915 | Hexa-D-Arginine (trifluoroacetate salt) | - | >95.00% | |
A furin inhibitor | ||||
| GC50716 | K 22 | 2141978-86-9 | >98.00% | |
An antiviral agent | ||||
| GC52045 | N-desmethyl Azelastine | 47491-38-3 | >98.00% | |
An active metabolite of azelastine | ||||
| GC52224 | (±)-MMT5-14 | 2719679-31-7 | >98.00% | |
A derivative of remdesivir with antiviral activity | ||||
| GC52230 | AA3-DLin | - | >95.00% | |
An ionizable cationic amino lipid | ||||
| GC52261 | Entecavir-d2 | 142217-69-4 | >99.00% | |
An internal standard for the quantification of entecavir | ||||